Loading…
Company raises $6 million and issues short-term warrants for up to $12 million
Purple Biotech announced Purple Biotech announced a public offering of approximately 6 million American Depositary Shares (ADSs) or pre-funded warrants at a combined price of $1.00, raising $6 million. Additionally, short-term warrants to purchase up to approximately 12 million ADSs at $1.00 were issued, potentially raising up to $12 million in additional proceeds.
The announcement cited $6M, ~6M ADSs, $1.00, ~12M ADSs, and $12M. Share consideration (payable in the issuer's shares): 6M ADSs.
PURPLE BIOTECH LTD. has a free float of 508,630,000 shares and 9,030,400 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.